CoLucid Pharmaceuticals
Durham, US · Delaware corporation · 3 known investors
Founders & leadership
BK
Bernice KucaExecutive
MP
Mathers P. ThomasExecutive
NR
Nadia RupniakExecutive
TC
Timothy C. GuptonExecutive
Board
JI
RJ
Richard J. MarkhamBoard director
AM
Arthur M. PappasBoard director
ME
Martin EdwardsBoard director
LM
Luc MarengereBoard director
Investors · 3
Reported raises · per SEC filings
Form D private placements$37.1M disclosed across 1 round · 2015
▶$37.1MraisedJan 2015 · 11 investors · PharmaceuticalsRule 506(b)
▶$37.1MraisedJan 2015 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bernice KucaExecutive Officer
- Mathers P. ThomasExecutive Officer, Director
- Jesse I. TreuDirector
- Nadia RupniakExecutive Officer
- Timothy C. GuptonExecutive Officer
- Richard J. MarkhamDirector
- Arthur M. PappasExecutive Officer, Director
- Martin EdwardsDirector
- Luc MarengereDirector
- Offering amount
- $37.1M
- Amount sold
- $37.1M
- First sale
- Jan 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are CoLucid Pharmaceuticals's investors?
- CoLucid Pharmaceuticals's investors include Pappas Capital, Domain Associates, TVM Capital.
- How much funding has CoLucid Pharmaceuticals raised?
- CoLucid Pharmaceuticals has disclosed $37.1M raised across 1 round.
- Where is CoLucid Pharmaceuticals headquartered?
- CoLucid Pharmaceuticals is headquartered in Durham, US.